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3 Address: Directorate General of Health Services, Al Dakhilya Governate, Oman. Tel.: +968 99434230.Mary K. Jacob a,⇑; Kiran P. Sawardekar b,1; Hani Gameel Ayoub a,2; Ibrahim Al Busaidi c,3AbstractPurpose: To study appropriateness of our modified screening criteria for detection of all cases of Retinopathy of Prematurity (ROP)
among preterm babies.
Method: Retrospective observational cohort study among preterm neonates who underwent ROP screening as per set protocol
for 11 years at Nizwa Hospital, Al Dhakilya Governorate, Oman. We screened all babies with gestational age 632 weeks or
BW 6 1500 g. Preterm babies >32 weeks of GA or BW > 1500 g with unstable clinical course believed to be at high risk by the
attending neonatologist also were screened.
Results: During the study period 528 babies were screened for ROP of which 76 babies were excluded due to death, associated
congenital ocular malformation and loss for follow-up either due to transfer to other institution or defaulting. Thus 452 babies were
included in the final analysis. Incidence of ROP was 46.4% of which 27.9% had mild ROP, 11.3% had severe ROP which regressed
and 7.3% had severe ROP who were treated. The incidence of ROP among infants with GA < 26 wks, 26–28 wks, 29–30 wks,
31–32 wks and above 32 weeks was 100.0%, 80.0%, 59.3%, 34.4% and 19.4% respectively.
56 babies of this cohort belonged to Extended (modified) criteria group. Among these 12 babies had ROP out of which 9 had mild
ROP and 3 had severe ROP. Among cases with severe ROP, two cases regressed spontaneously and one case needed treatment.
Multivariate analysis using stepwise regression model showed statistically significant association of GA and BW to development of
ROP.
We would have missed few babies with ROP if we had followed other criteria.
Conclusion: Our modified screening criteria seem to be appropriate as no infant with severe ROP was missed during the study
period. Incidence of severe ROP among babies in the extended criteria group (5.4%) is low but significant compared to lower ges-
tational age. We plan to formulate a scoring system following all risk factor analysis to enable us to optimize the number of infants
screened. Detection of all babies with ROP is important as they need long-term follow-up for the timely detection and manage-
ment of associated ocular comorbidities.
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Retinopathy of prematurity (ROP) is a vasoproliferative
disorder affecting preterm infants that can potentially lead
to blindness if not treated in time. With recent improvement
in neonatal care, extremely low birth weight babies and
extreme preterm babies are increasingly surviving and hence
the incidence of ROP has been frequently reported from
developing countries.
Retinopathy of prematurity was established in developed
countries at the end of 1980s after the American CRYO-
ROP study report was published.1 Some low and middle
income countries introduced ROP screening in the 1990s2
and some still do not have programmes or their screening
coverage is either low or only selectively implemented in
some urban centres.3 The aim of the screening should be
to target those who are most at risk, but the gold standard
remains to detect and treat every possible case of ROP.
The profile of babies developing ROP in countries with mod-
erate and low human development index differs from coun-
tries with high human development index as bigger and
more mature babies are also found to develop this disorder
in these settings.2,4,5
The United Kingdom (UK) screening guidelines by the
Royal College of Ophthalmologists, UK and British Associa-
tion of Perinatal Medicine (RCOS-BAPM) recommend screen-
ing of infants with gestational age (GA) less than 32 weeks
(up to 31 weeks and 6 days) or birth weight (BW) less than
1501 g.6 The American Academy of Paediatrics (AAP)
updated the recommendations and has proposed screening
for infants with BW 6 1500 g or GA 6 30 weeks with a
caveat to screen heavy and older babies with unstable
clinical course.7,8 These criteria seem to have worked well
in countries with high human development index.9 In view
of the inconsistency in the GA and BW of babies with
severe ROP in the literature, we cannot generalize the
screening criteria to all neonatal units, regions and popula-
tions alike.5,10,11
The low incidence of ROP and related blindness in devel-
oped nations are due to reasons including population and
ethnic variations, neonatal care and organized screening
and timely intervention.9 There is a great variation in the stan-
dards of neonatal care and neonatal outcomes in different
settings worldwide and hence population/institution based
criteria are necessary to achieve optimal detection rates.12
Moreover, the incidence of ROP and the need for treatment
vary due to the difference in the screening criteria, observer
difference as well as ethnic variation in susceptibility. To pre-
vent adverse effects from ROP, it is mandatory to assess the
population at risk, to identify the risk factors and to adopt
appropriate screening criteria. This is the first study under-
taken in Oman till date to validate the appropriateness of
our modified ROP screening criteria. Previous studies on
ROP in Oman focused on risk factors and aetiology of
ROP.13,14Materials and methods
This is a retrospective cohort study conducted in the Spe-
cial Care Baby Unit (SCBU) and Medical Retina Clinic of
Nizwa hospital, a governorate referral hospital in Al Dakhaliya
governorate in Oman. This study was approved by the localresearch and ethical committee. It was conducted for a per-
iod of 11 years from January 1, 2003 to December 31, 2013.
We screened all the preterm babies with GA 6 32 weeks
or BW 6 1500 g. Besides, preterm babies >32 weeks (up to
36 weeks) of GA or BW 1501–2000 g with any of additional
risk factors such as prolonged ventilatory support more than
10 days, prolonged oxygen therapy beyond 36 weeks of
postconceptual age, life threatening recurrent apnoeas,
anaemias needing more than 4 blood transfusions and gram
negative or fungal neonatal sepsis were also screened at the
discretion of neonatologist. (Extended criteria group).
The data of all babies who underwent screening for ROP
during the study period were retrospectively reviewed. Data
collected for each neonate included gender, plurality, GA,
BW, postmenstrual age, age of onset of ROP and age at
which treatment was carried out and nature of treatment. In
many cases it was found that both eyes were affected except
in 20 cases. Most severely affected eye was included in ROP
grading, when ROP involved both the eyes. Initial screening
was done at 31 weeks of postmenstrual age in babies with
GA < 27 weeks and at 4 weeks of postnatal age in babies
born with GA > 27 Weeks.7 Gestational age was calculated
from the history given by the pregnant mothers about their
last menstrual period (LMP). When there was a discrepancy,
the mean of GA by LMP and GA by ultrasound was com-
puted. Screening was done exclusively by two of the senior
ophthalmologists with expertise in ROP.
Pupillary dilatation was done with 1% Phenylephrine and
0.5% Tropicamide starting two hours before the examination.
Fundoscopy was done with binocular indirect ophthalmo-
scope using +28 Diopter Volk lens. Paediatric speculum
and scleral depressor were used whenever needed. ROP
was classified based on the international classification of
ROP.15 In cases of Immature retina, follow-up examinations
were made every two weeks till the vessels reached retinal
periphery. On detection of ROP, babies were reviewed
weekly or more frequently as per the discretion of the oph-
thalmologist. ROP stages 1 and 2 were labelled as mild
ROP, and Stages 3–5 and aggressive posterior ROP were
labelled as severe ROP.
Decision for treatment was taken as described in ‘‘Early
Treatment of ROP randomized Trial’’ (ET-ROP).16 Infants with
severe ROP needing treatment were also reviewed by vitreo-
retinal surgeons at tertiary care ophthalmic service and treat-
ment was carried out after their ratification. Treatment was
by Laser photocoagulation till year 2009 and either Laser
treatment and/or intravitreal injection of Anti Vascular
Endothelial Growth Factor agent during period after year
2009. Treatment was carried out within 72 h of decision to
treat.
Statistical analysis was carried out using commercially
available statistical software package (SPSS version 16). We
considered the p value to be statistically significant when it
was less than 0.05. Chi square test and logistic regression
were used to find the odds ratio in univariate and multivariate
analysis respectively.Results
Among the 528 babies screened for ROP during the study
period, seven babies expired before completing the ROP
evaluation and two were excluded due to associated
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up due to either transfer to other institutions or defaulting.
Thus 76/528 (14.4%) excluded for reasons cited earlier and
452 babies included for final analysis. 396 babies (87.6%)
belonged to standard criteria group and 56 babies (12.4%)
of this cohort belonged to the extended criteria group.
58.6% of the babies were male and 41.4% were female.
79.4% of the babies had GA up to 32 weeks and 20.6% of
the babies had GA > 32 weeks. 66.1% babies had
BW 6 1.5 kg and 33.8% babies had birth weight >1.5 kg.
77.6% of the babies were born out of singleton pregnancy
and 22.3% were born out of multiple pregnancy. Total inci-
dence of ROP in our cohort was 46.4% of which 27.9% had
mild ROP, 11.3% had severe ROP which regressed and 7.3%
had severe ROP who were treated.
Fig. 1 is the scatter plot showing the relation of screening
criteria of GA and BW with respect to ROP.
The incidence of ROP among infants with GA < 26 wks,
26–28 wks, 29–30 wks, 31–32 wks and >32 weeks was
100.0%, 80.0%, 59.3%, 34.4% and 19.4% respectively. The
odds ratio shows that as GA increased, the risk of ROP
decreased and the association between ROP and GA was
statistically significant (p < 0.001).
The incidence of ROP among males (48.3%) was slightly
higher than that of female babies (44.1%), however the asso-
ciation with gender was not statistically significant
(p = 0.616). The incidence of ROP among singleton babies
(47%) almost matched with incidence among babies born
out of multiple pregnancies (46.4%) and was statistically
insignificant (p = 0.913).
Table 1 shows different stages of ROP and its relation to
GA and BW.
56 babies of this cohort belonged to extended criteria
group. Among this 12 (21.4%) babies had ROP out of which
nine (16.1%) were mild ROP and three (5.3%) were severe
ROP. Among severe ROP two regressed spontaneously and
one underwent treatment. Their mean BW was 1.97 Kg and
GA was 33.68 weeks which was higher than babies with
ROP in standard criteria group.
We used stepwise logistic regression model to carry out
multivariate analysis only of demographic variables. We
included GA, BW, sex and plurality as independent risk fac-
tors. We found that GA was the most important risk factor
for ROP (P < 0.001). The other risk factors were not signifi-
cantly associated with ROP on multivariate analysis. The asso-
ciation between clinical risk factors (maternal, infant and
interventional) and severity of ROP is not part of this study
and will be reported elsewhere.
Discussion
In spite of recent developments in diagnosis and manage-
ment, ROP represents a leading cause of preventable blind-
ness in childhood. Retinopathy of prematurity is targeted in
‘‘Vision 2020’’ which is a global initiative with a mission to
eliminate the cause of all preventable and treatable blindness
by year 2020.17
Our study shows an incidence of ROP of 46.4% which is
higher than an incidence of 34%13 and 25.4%14 respectively
as reported from tertiary neonatal units in Oman. These ear-
lier studies were over a shorter period of time and due toreferral bias of tertiary centre cohort, cannot be applied to
general population cohort as in our study.
Table 2 shows the incidence of ROP reported from some
of the Middle Eastern countries in the recent past.
An analysis of incidence of ROP in Middle Eastern coun-
tries indicates that although total incidence of ROP shows
wide range between 23.31% and 56%, the rates of threshold
and severe ROP and severe ROP needing treatment are com-
parable. To illustrate further the percentage of severe ROP
needing treatment of 6.48% in Amer et al. study in Saudi Ara-
bia9 (Total ROP incidence 23.31%) is almost comparable to
severe ROP needing treatment of 7.3% in our study (Total
ROP incidence 46.4%).
No gender difference was seen in the incidence of ROP
which is consistent with CRYO-ROP study and the New York
Cohort.22–24 Gender and plurality were not associated with
severity of ROP, a finding similar to other studies.12,25 Wag-
ner reported a higher incidence of ROP in older and more
mature infants in his special report on the ‘‘ROP epidemiol-
ogy in developing countries.’’ 26 Several reports of ROP in
heavier and older babies from Indian subcontinent, China
and rest of Asia, have emphasized the occurence of ROP in
babies above BAPM or AAP criteria.27 Dogra reported
15.3% of threshold ROP28 and Deshpande reported an inci-
dence of 21.7% of threshold ROP29 in babies with
BW > 1500 g in India. Vinekar et al. from a tertiary neonatal
intensive care unit in India reported that 62/138 of their
babies (45%) with a mean BW of 1533 g (range 1251–2750)
had threshold ROP.11 Similarly Chen et al. reported among
cases with severe ROP in China, 27.2% babies were more
than 1500 g at birth.30 Thus widening scope of ROP screen-
ing is desirable in several parts of the world so as to not to
miss any cases with ROP. However, more detailed studies
are required to further narrow down the basis for screening
in this group. Screening five or six extra preterms yearly (56
babies in 11 years) did not cause excessive burden on our
ROP screening services.
Moreover, why then in the western countries with high
human development index, ROP especially blinding ROP is
not reported in heavier or more mature preterm babies? It
could be due to population characteristics such as ethnicity
or genetic predisposition, optimal standards of neonatal care
allowing careful control of risk factors, optimal ROP screen-
ing and its timely intervention. Besides it could be that there
are not many studies which have explored the ROP in pre-
term babies in GA between 32 and 36 weeks and BW bands
of 1500–2000 g in their settings. Chiang et al. did report in
their study on neonates from New York state in USA that
17 of their infants with ROP were more than 2000 g in BW
although none required treatment.31 However on the other
side of the spectrum especially from the Indian subcontinent
high incidence of blinding ROP is reported in heavier and
more mature babies.11,32 This may possibly be due to unreg-
ulated neonatal care practices especially administration of
high concentration of unblended oxygen without proper
monitoring, suboptimal ROP screening programme due to
non-availability of trained ophthalmologist and timely inter-
vention facilities.32
Although we used ‘‘sickness criteria’’ for recommending
babies for ROP screening beyond the GA cut-off of 32 weeks
and or BW cut-off of 1500 g, such a proposition is difficult to
Figure 1. Scatter plot showing the relation of gestational age and birth weight to ROP screening results.
Table 1. ROP staging in relation to gestational age and birth weight.
NO (%) Mean gestational age weeks (range) Mean birth weight (range)
No ROP 242 (53.5) 31.59 (27–36) 1.55 (1.0–3.0)
ROP stage 1 35 (7.7) 30.74 (26–35) 1.41 (0.7–2.2)
ROP stage 2 91 (20.1) 29.92 (25–34) 1.37 (0.7–2.2)
ROP stage 3 not treated 51 (11.3) 28.8 (24–33) 1.16 (0.6–1.8)
Advanced ROP treated 33 (7.3) 28.09 (25–33) 1.08 (0.7–2.0)
6 M.K. Jacob et al.implement. This is because besides GA and oxygen expo-
sure, association between sickness criteria and ROP has
shown wide variations among several studies in the published
literature. Several of risk factors such as necrotizing entero-
colitis, symptomatic patent ductus arteriosus, intra-
ventricular haemorrhage, and sepsis are co-morbidities
observed in preterm infants during the same period as when
ROP is observed and may purely be epiphenomena rather
than having causal relationship.Table 2. Incidence of ROP from Middle Eastern Countries.
S. no Study, Country, Reference Year of pu
1 Amer et al., Saudi Arabia, 9 2012
2 Al Amro et al., Saudi Arabia, 18 2003
3 Binkhathlan et al., Saudi Arabia, 19 2008
4 Karkhaneh et al., Iran, 20 2008
5 Sarikabadayi et al., Turkey, 21 2011
6 Current study, Nizwa Hospital, Oman 2015Our data show that we would have missed few babies with
ROP if we had followed exclusively RCOS-BAPM criteria
(Table 3). Detection of ROP, even though they may regress
without intervention is important as these babies need
long-term follow-up for the timely detection and manage-
ment of ocular comorbidities such as refractive error, strabis-
mus and amblyopia.33
In conclusion, we suggest that in our set-up in Oman with
moderate human development index of 56 in 2015,34 weblication Duration of study Incidence of ROP
3 yrs 23.3
3.5 yrs 37.4
1 yr 56
4 yrs 34.5
1 yr 32.7
11 yrs 46.4
Table 3. Number of infants with ROP who would have missed if we have
used different screening criteria.
Screening criteria No of
Infants
fulfilling
criteria
Number of Infants
that would have
missed
ROP
positive
cases
Severe
ROP
treated
Present criteria in the study 452 0 0
If we haven’t screened babies
with GA > 32 wks and
BW > 1.5 kg
56 12 1
Detection of all cases of Retinopathy of Prematurity among preterm babies 7should also screen all babies with additional risk factors espe-
cially in GA range of 32–34 weeks and BW band 1500–1800 g
for risk of ROP. Beyond this cut-off, severe ROP is excep-
tional in our set-up. The observation of not detecting any
other children with low vision who had preterm birth in our
governorate indirectly suggests that possibly no preterm
babies other than in our cohort had ROP related blindness.
Our study has few limitations. The study being retrospec-
tive in nature has its own inherent limitations. Besides our
study sample covered only one governorate and cannot be
generalized to whole of Oman. We also lost 67 (12.7%)
babies to follow-up whose outcome is not known which could
have skewed the result. Since neonatal survival and care dif-
fer in different centres, it is also advisable to evaluate the
effectiveness of the proposed modified screening system in
other governorates and hospitals. This will help to formulate
an appropriate national screening programme in Oman and
other Middle Eastern countries with Arab lineage, in the
future.
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